Sotorasib Plus Panitumumab Significantly Improves Outcomes in Colorectal Cancer

Combination treatment of sotorasib plus panitumumab prolongs progression-free survival in those with metastatic colorectal cancer and the KRAS G12C mutation.

Related Keywords

Japan ,Vectibix Amgen ,Sotorasib Lumakras ,Ravil Sayfullin ,Amgen ,University Of Connecticut ,Taiho Oncology ,Pharmacy Leaders Track ,Lambda Kappa Sigma ,Phi Lambda Sigma ,